The global sinusitis treatment market size was valued at US$ 3 bn in 2020 and is expected to reach US$ 4.3 billion by 2030 with at a CAGR of 4.1% from 2021 to 2030.
Sinuses are a connected system of air-filled cavities located in the skull. Sinusitis is an inflammation of the sinus lining caused by bacteria, virus, fungi, and microbes. Bacterial sinusitis is less common than viral sinusitis and requires antibiotics, while viral sinusitis is most common and does not require antibiotics.
Fungal sinusitis is also known as allergic fungal sinusitis and is caused by aspergillosis fungi. Possible symptoms of sinus infection are nasal obstruction, discolored nasal discharge, and facial pain that lasts for seven days or more. Facial pain is a common symptom in sinusitis. A patient could feel pain around the eye, forehead, nose, and root of teeth. There are three primary types of sinusitis: acute sinusitis, sub-acute sinusitis, and chronic sinusitis.
Acute rhinosinusitis is a general disease with global prevalence. The disease is a major burden on health services. Rhinosinusitis is a major health problem globally. It is an infection of the nasal passages and paranasal sinuses.
Primary care physicians usually tend to think of sinusitis as an acute bacterial infection. Hence, antibiotics are prescribed to 92% of patients in the U.K. and 85% to 98% of sinusitis patients in the U.S. In 2003, the number of medical prescriptions for acute bacterial sinusitis was around 7.6 million in Germany. In France, around 7% of all antibiotics are prescribed to treat suspected acute bacterial sinusitis.
The annual cost of treatment in the U.K. is GBP 10 Mn (EUR 14.7 Mn, US$ 20 Mn). In 1996, the total cost of prescription and non‐prescription medications used for the treatment of sinusitis in the U.S. was around US$ 3.39 Bn (EUR 2.5 Bn, GBP 1.7 Bn). Rhinosinusitis accounted for around 12 million to 17 million annual visits to physicians and 12% of antibiotics prescribed to geriatric patients in the U.S., making it one of the 10 most common conditions to be treated in ambulatory practice. Hence, increase in cases of acute rhinosinusitis is projected to fuel the growth of the global sinusitis treatment market.
In terms of treatment, the global sinusitis treatment market has been classified into analgesics, antihistamines, corticosteroids, antibiotics, sulphonamides, quinolones, and surgery. Antibiotics have been split into cephalosporin, penicillin, and macrolide. The surgery segment has been bifurcated into endoscopy and balloon sinusplasty. The antihistamines segment accounted for 32% share of the global market in 2020. The segment is anticipated to expand at a CAGR of 3.8% from 2021 to 2030. Antihistamines are over-the-counter medication used to relieve cold, sinus, and allergy symptoms. Hence, increase in usage of these drugs boosts the growth of the segment.
Based on disease type, the global sinusitis treatment market has been categorized into acute sinusitis, sub-acute sinusitis, and chronic sinusitis. The acute sinusitis segment accounted for 35% share of the market in 2020. The segment is expected to expand at a CAGR of 4% from 2021 to 2030. Acute sinusitis is generally caused by common cold. Signs and symptoms could include nasal obstruction and congestion, which may block sinuses in patients and prevent drainage of mucus. Hence, rise in cases of common cold & flu increases the incidence of acute sinusitis. This, in turn, propels the global sinusitis treatment market.
In terms of route of administration, the global sinusitis treatment market has been segregated into topical, nasal, oral, and injectable. The oral segment accounted for 60% share of the global market in 2020. The segment is projected to expand at a CAGR of 3.7% from 2021 to 2030. The oral pathway has attracted the most attention due to unique advantages, including sustained and controllable delivery, feasibility for solid formulations, ease of administration, patient compliance, and an intensified immune response in the case of vaccines.
Based on distribution channel, the global sinusitis treatment market has been divided into online pharmacies, retail pharmacies, and hospital pharmacies. The retail pharmacies segment held 44% share of the market in 2020. The segment is likely to gain market share marginally to reach 44.7% by 2030, as drugs are easily available and various brands are offered at reasonable prices at retail pharmacies.
In terms of region, the global sinusitis treatment market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for a significant share of the global market because of higher prevalence of sinusitis. According to the Centers for Disease Control and Prevention (CDC), nearly 26.8 million people were diagnosed with sinusitis in the U.S. in 2019. Europe is anticipated to be a key market for sinusitis treatment due to rise in invasive bacterial diseases and innovation in diagnosis of bacterial infections.
The sinusitis treatment market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to increase in bacterial and viral diseases. However, factors, such as lack of knowledge of diagnostic tests and awareness among people about sinusitis is likely to hamper the growth of the market in the region.
Competitive Landscape and Market Share Analysis
The sinusitis treatment market competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, sinusitis treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2017-2020, this study provides the sinusitis treatment sales, revenue and market share for each player covered in this report.
The global sinusitis treatment market is fragmented due to the presence of a large number of leading players. Key players operating in the global market include Sun Pharmaceutical Industries, Inc., Pfizer, Inc., Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Fresenius Kabi USA, LLC, Dr. Reddy's Laboratories, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi, Abbott Laboratories, Bayer AG, Eli Lilly and Company, Bristol-Myers Squibb, Merck & Co, Inc., AstraZeneca plc, Amneal Pharmaceuticals LLC, GlaxoSmithKline plc., Aurobindo Pharma, Hikma Pharmaceuticals plc, Wockhardt, and Mylan N.V.
Global Sinusitis Treatment Market: Segmentation
Sinusitis Treatment Market, By Treatment
Sinusitis Treatment Market, By Disease Type
Sinusitis Treatment Market, By Route of Administration
Sinusitis Treatment Market, By Distribution Channel
Sinusitis Treatment Market, By Region
This report focuses on sinusitis treatment market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall sinusitis treatment market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global sinusitis treatment market.
The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.
In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the sinusitis treatment market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the sinusitis treatment market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Sinusitis treatment market.
Market Segments: This part of the report discusses about product, application and other segments of the sinusitis treatment market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses about the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global sinusitis treatment market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the sinusitis treatment market.
The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.
The research methodology adopted by analysts for compiling the global sinusitis treatment market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global sinusitis treatment market.
The study objectives of this report are:
Hyaluronic Acid Market (By Application: Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
AI in Oncology Market (By Treatment: Chemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy; By Cancer Type; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Paracetamol IV Market (By Application: Surgical, Non-surgical; By Indication: Pyrexia, Pain; By End-use: Hospitals, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Healthcare Companion Robots Market (By Type: Animal-like Robots, Humanoid Robots; By Age Group) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Rare Diseases Treatment Market (By Therapeutic Area: Cancer, Musculoskeletal Conditions; By Route of Administration; By Drug Type; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...